Recombinant mistletoe lectin (rML) is successful in treating human ovarian cancer cells transplanted into severe combined immunodeficient (SCID) mice

✍ Scribed by Udo Schumacher; Susanne Feldhaus; Ulrich Mengs

• Book ID: 117469740
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 96 KB
• Volume: 150
• Category: Article
• ISSN: 0304-3835
• DOI: 10.1016/s0304-3835(99)00387-0